Nancy J. Cox

Q: What Schools Are Affiliated With Nancy J. Cox

Nancy J. Cox is affiliated with the following schools: University of Cambridge, University of Colorado Boulder, New York Medical College, University of California, Irvine, University of Hong Kong, University of Florida, Auburn University, Icahn School of Medicine at Mount Sinai, Cornell University, Texas A&M University, Pompeu Fabra University

Nancy J. Cox's AcademicInfluence.com Rankings

Nancy J. Cox

Philosophy

#5412

World Rank

#8204

Historical Rank

Logic

#2699

World Rank

#3729

Historical Rank

philosophy Degrees

Nancy J. Cox

Biology

#7229

World Rank

#10121

Historical Rank

Genetics

#685

World Rank

#771

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Nancy J. Cox's Degrees

PhD Human Genetics University of Chicago
Doctorate Medicine University of Chicago

Why Is Nancy J. Cox Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Nancy J. Cox's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A novel coronavirus associated with severe acute respiratory syndrome. (2003) (4084)
MORTALITY ASSOCIATED WITH INFLUENZA AND RESPIRATORY SYNCYTIAL VIRUS IN THE UNITED STATES (2002) (3656)
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). (2004) (2557)
Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans (2009) (2458)
Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). (2006) (2456)
Influenza-associated hospitalizations in the United States. (2004) (2179)
Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. (1998) (1404)
Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. (2009) (1301)
Characterization of the Reconstructed 1918 Spanish Influenza Pandemic Virus (2005) (1203)
Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses (2009) (1149)
Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. (2009) (1047)
A distinct lineage of influenza A virus from bats (2012) (1028)
Influenza surveillance--United States, 1992-93 and 1993-94. (1997) (985)
Probable person-to-person transmission of avian influenza A (H5N1). (2005) (865)
Global epidemiology of influenza: past and present. (2000) (833)
Detection of Antibody to Avian Influenza A (H5N1) Virus in Human Serum by Using a Combination of Serologic Assays (1999) (831)
Estimates of deaths associated with seasonal influenza --- United States, 1976-2007. (2010) (764)
Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern (2005) (741)
Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. (1998) (721)
The Global Circulation of Seasonal Influenza A (H3N2) Viruses (2008) (692)
Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong. (1999) (690)
Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. (2000) (687)
The economic impact of pandemic influenza in the United States: priorities for intervention. (1999) (677)
Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. (2006) (672)
Transmission and Pathogenesis of Swine-Origin 2009 A(H1N1) Influenza Viruses in Ferrets and Mice (2009) (665)
Influenza-associated deaths among children in the United States, 2003-2004. (2005) (637)
Transmission of Equine Influenza Virus to Dogs (2005) (624)
Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. (2000) (618)
Structural basis of immune recognition of influenza virus hemagglutinin. (1990) (577)
A Two-Amino Acid Change in the Hemagglutinin of the 1918 Influenza Virus Abolishes Transmission (2007) (552)
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. (2010) (544)
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). (2002) (539)
Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. (2007) (535)
Predicting the evolution of human influenza A. (1999) (518)
The impact of influenza epidemics on hospitalizations. (2000) (500)
Avian Influenza (H5N1) Viruses Isolated from Humans in Asia in 2004 Exhibit Increased Virulence in Mammals (2005) (482)
Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. (2009) (442)
A Mouse Model for the Evaluation of Pathogenesis and Immunity to Influenza A (H5N1) Viruses Isolated from Humans (1999) (412)
Global circulation patterns of seasonal influenza viruses vary with antigenic drift (2015) (402)
Evolution of H5N1 Avian Influenza Viruses in Asia (2005) (383)
Long term trends in the evolution of H(3) HA1 human influenza type A. (1997) (383)
Comparisons of Highly Virulent H5N1 Influenza A Viruses Isolated from Humans and Chickens from Hong Kong (1998) (367)
Three Indonesian clusters of H5N1 virus infection in 2005. (2006) (347)
Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices--United States, 2013-2014. (2013) (341)
Lack of transmission of H5N1 avian–human reassortant influenza viruses in a ferret model (2006) (340)
Positive selection on the H3 hemagglutinin gene of human influenza virus A. (1999) (327)
Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. (2000) (318)
Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: multiple evolutionary pathways and sequential amino acid changes at key antigenic sites (1983) (313)
Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997-1998. (2002) (308)
Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997. (1999) (298)
Prevention and control of influenza (1999) (283)
Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. (2003) (264)
Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. (1999) (261)
Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong. (2000) (248)
Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. (2008) (246)
Isolation and Characterization of Avian Influenza Viruses, Including Highly Pathogenic H5N1, from Poultry in Live Bird Markets in Hanoi, Vietnam, in 2001 (2005) (236)
Seasonal influenza vaccines. (2009) (229)
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) — United States, 2014–15 Influenza Season (2014) (228)
Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. (2008) (221)
Global concerns regarding novel influenza A (H7N9) virus infections. (2013) (219)
Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein. (1995) (198)
Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. (2012) (195)
Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis. (1995) (192)
In vitro evolution of H5N1 avian influenza virus toward human-type receptor specificity. (2012) (190)
Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. (1993) (182)
Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. (2009) (182)
Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. (2006) (180)
Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults. (1998) (178)
Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998. (1999) (176)
Serologic Evidence of H1 Swine Influenza Virus Infection in Swine Farm Residents and Employees (2002) (171)
Genetic analysis of human H2N2 and early H3N2 influenza viruses, 1957-1972: evidence for genetic divergence and multiple reassortment events. (2004) (168)
Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 northern hemisphere season. (2010) (166)
Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons. (2002) (165)
Early Estimates of Seasonal Influenza Vaccine Effectiveness — United States, January 2013 (2013) (161)
Genetic Compatibility and Virulence of Reassortants Derived from Contemporary Avian H5N1 and Human H3N2 Influenza A Viruses (2008) (160)
The antigenicity and evolution of influenza H1 haemagglutinin, from 1950-1957 and 1977-1983: two pathways from one gene. (1986) (158)
Outbreak of Variant Influenza A(H3N2) Virus in the United States (2013) (150)
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. (2007) (148)
Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2). (1988) (138)
Polygenic virulence factors involved in pathogenesis of 1997 Hong Kong H5N1 influenza viruses in mice. (2007) (132)
Estimated Influenza Illnesses and Hospitalizations Averted by Vaccination — United States, 2013–14 Influenza Season (2014) (132)
Molecular changes associated with the transmission of avian influenza a H5N1 and H9N2 viruses to humans * (2002) (131)
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). (2004) (130)
Experimental Evaluation of the FluChip Diagnostic Microarray for Influenza Virus Surveillance (2006) (128)
Evolution of Highly Pathogenic H5N1 Avian Influenza Viruses in Vietnam between 2001 and 2007 (2008) (124)
Studies of the 1996-1997 inactivated influenza vaccine among children attending day care: immunologic response, protection against infection, and clinical effectiveness. (2000) (121)
Pathogenesis and transmission of swine origin A(H3N2)v influenza viruses in ferrets (2012) (121)
The molecular epidemiology of influenza viruses (1995) (120)
Low incidence of rimantadine resistance in field isolates of influenza A viruses. (1999) (116)
Reassortment between Avian H5N1 and Human H3N2 Influenza Viruses in Ferrets: a Public Health Risk Assessment (2009) (116)
Using live, attenuated influenza vaccine for prevention and control of influenza: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP). (2003) (115)
Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome. (2008) (113)
Family Clustering of Avian Influenza A (H5N1) (2005) (113)
The total influenza vaccine failure of 1947 revisited: Major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic (2002) (109)
Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses. (2006) (106)
Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza H5N1 viruses. (2011) (103)
Comparison of 10 influenza A (H1N1 and H3N2) haemagglutinin sequences obtained directly from clinical specimens to those of MDCK cell- and egg-grown viruses. (1993) (102)
The development of vaccine viruses against pandemic A(H1N1) influenza. (2011) (101)
Laboratory characterization of a swine influenza virus isolated from a fatal case of human influenza (1989) (100)
Lack of Evidence for Human-to-Human Transmission of Avian Influenza A (H9N2) Viruses in Hong Kong, China 1999 (2002) (99)
Antigenic and genetic variation in influenza A (H1N1) virus isolates recovered from a persistently infected immunodeficient child (1991) (96)
WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013. (2014) (95)
Continuing progress towards a unified nomenclature for the highly pathogenic H5N1 avian influenza viruses: Divergence of clade 2·2 viruses (2009) (94)
Influenza Activity — United States, 2013–14 Season and Composition of the 2014–15 Influenza Vaccines (2014) (92)
Immunohistochemical and in situ hybridization studies of influenza A virus infection in human lungs. (2000) (91)
Interim Adjusted Estimates of Seasonal Influenza Vaccine Effectiveness — United States, February 2013 (2013) (91)
17 – Inactivated influenza vaccines (2013) (90)
Effects of passage history and sampling bias on phylogenetic reconstruction of human influenza A evolution. (2000) (89)
An influenza A (H1N1) virus, closely related to swine influenza virus, responsible for a fatal case of human influenza (1994) (87)
Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2). (2011) (87)
The occurrence of hepatitis A and astroviruses in selected river and dam waters in South Africa. (2001) (87)
Influenza Activity — United States, 2012–13 Season and Composition of the 2013–14 Influenza Vaccine (2013) (86)
Detecting 2009 pandemic influenza A (H1N1) virus infection: availability of diagnostic testing led to rapid pandemic response. (2011) (86)
Avian-to-human transmission of H 9 N 2 subtype influenza A viruses : Relationship between H 9 N 2 and H 5 N 1 human isolates (2000) (85)
Influenza pandemic planning. (2003) (85)
Receptor Specificity of Influenza A H3N2 Viruses Isolated in Mammalian Cells and Embryonated Chicken Eggs (2010) (83)
Reassortment and evolution of current human influenza A and B viruses. (2004) (83)
Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 25 degrees between recent H3N2 and H1N1 epidemic strains and cold-adapted A/An Arbor/6/60. (1979) (83)
A Method for Timely Assessment of Influenza‐Associated Mortality in the United States (1997) (82)
Comparison of US inactivated split-virus and Russian live attenuated, cold-adapted trivalent influenza vaccines in Russian schoolchildren. (1996) (82)
Influenza A virus nucleoprotein induces apoptosis in human airway epithelial cells: implications of a novel interaction between nucleoprotein and host protein Clusterin (2013) (81)
Effect of D222G Mutation in the Hemagglutinin Protein on Receptor Binding, Pathogenesis and Transmissibility of the 2009 Pandemic H1N1 Influenza Virus (2011) (81)
Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents. (2000) (79)
Recombination of human influenza A viruses in nature (1980) (79)
Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry. (2008) (78)
Updated preparedness and response framework for influenza pandemics. (2014) (78)
Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14–16 June 2010 (2013) (76)
Transmission and Pathogenesis of Swine-Origin 2009 A ( H 1 N 1 ) Influenza Viruses in Ferrets and Mice Citation (2010) (76)
Influenza A Virus Nucleoprotein Exploits Hsp40 to Inhibit PKR Activation (2011) (76)
Characterization of drug-resistant influenza A(H7N9) variants isolated from an oseltamivir-treated patient in Taiwan. (2015) (75)
Influenza pandemic preparedness plan for the United States. (1997) (74)
Infection of a child in Hong Kong by an influenza A H3N2 virus closely related to viruses circulating in European pigs. (2001) (72)
Receptor specificity of subtype H1 influenza A viruses isolated from swine and humans in the United States. (2011) (71)
Highly Pathogenic Avian Influenza A(H7N3) Virus in Poultry Workers, Mexico, 2012 (2013) (69)
Type- and subtype-specific detection of influenza viruses in clinical specimens by rapid culture assay (1995) (69)
MChip: a tool for influenza surveillance. (2006) (68)
Evidence for two subtypes of Ebola virus based on oligonucleotide mapping of RNA. (1983) (68)
Pathogenesis, Transmissibility, and Ocular Tropism of a Highly Pathogenic Avian Influenza A (H7N3) Virus Associated with Human Conjunctivitis (2013) (68)
Amantadine-resistant influenza A in nursing homes. Identification of a resistant virus prior to drug use. (1995) (68)
Influenza A virus infection complicated by fatal myocarditis. (2000) (67)
Antigenic and Genetic Diversity of Highly Pathogenic Avian Influenza A (H5N1) Viruses Isolated in Egypt (2010) (67)
Identification of A/H5N1 influenza viruses using a single gene diagnostic microarray. (2007) (66)
WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011. (2012) (66)
Physicochemical properties of Marburg virus: evidence for three distinct virus strains and their relationship to Ebola virus. (1988) (66)
65 years of influenza surveillance by a World Health Organization‐coordinated global network (2018) (65)
Generation and evaluation of a high-growth reassortant H9N2 influenza A virus as a pandemic vaccine candidate. (2003) (65)
The first confirmed human case of avian influenza A (H5N1) in Mainland China (2006) (65)
Human influenza A (H1N2) viruses isolated from China. (1992) (65)
SURVEILLANCE FOR INFLUENZA - UNITED STATES, 1997–98, 1998–99, AND 1999–00 SEASONS (2002) (64)
Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate. (2003) (63)
Pandemic preparedness and the Influenza Risk Assessment Tool (IRAT). (2014) (62)
Pandemic Influenza Planning, United States, 1978–2008 (2013) (61)
Sequence changes in the live attenuated, cold-adapted variants of influenza A/Leningrad/134/57 (H2N2) virus. (1992) (61)
Genetic variation in neuraminidase genes of influenza A (H3N2) viruses. (1996) (61)
Intercontinental circulation of human influenza A(H1N2) reassortant viruses during the 2001-2002 influenza season. (2002) (59)
Update: influenza activity--United States, September 28, 2008-April 4, 2009, and composition of the 2009-10 influenza vaccine. (2009) (59)
Pathways of evolution of influenza A (H1N1) viruses from 1977 to 1986 as determined by oligonucleotide mapping and sequencing studies. (1989) (58)
Selection of antigenically advanced variants of seasonal influenza viruses (2016) (57)
Improving influenza vaccine virus selectionReport of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14–16 June 2010 (2011) (56)
PCR restriction analysis of genome composition and stability of cold-adapted reassortant live influenza vaccines. (1995) (56)
Structural Stability of Influenza A(H1N1)pdm09 Virus Hemagglutinins (2014) (55)
Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential. (2006) (54)
Estimated Influenza Illnesses and Hospitalizations Averted by Influenza Vaccination — United States, 2012–13 Influenza Season (2013) (54)
Lack of significant person-to-person spread of swine influenza-like virus following fatal infection in an immunocompromised child. (1984) (54)
Evaluation of A/Alaska/6/77 (H3N2) cold-adapted recombinant viruses derived from A/Ann Arbor/6/60 cold-adapted donor virus in adult seronegative volunteers (1981) (53)
Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014. (2015) (53)
Surveillance for influenza--United States, 1994-95, 1995-96, and 1996-97 seasons. (2000) (52)
Characterization of a highly pathogenic avian influenza H5N1 virus sublineage in poultry seized at ports of entry into Vietnam. (2009) (51)
Development of Framework for Assessing Influenza Virus Pandemic Risk (2015) (50)
Effectiveness and Cost-Benefit of Influenza Vaccination of Healthy Working Adults (2008) (49)
Antibodies cross-reactive to influenza A (H3N2) variant virus and impact of 2010-11 seasonal influenza vaccine on cross-reactive antibodies - United States. (2012) (49)
Antigenic drift in the evolution of H1N1 influenza A viruses resulting from deletion of a single amino acid in the haemagglutinin gene. (2007) (49)
Laboratory-based surveillance of influenza A(H1N1) and A(H3N2) viruses in 1980-81: antigenic and genomic analyses. (1983) (48)
Antigenicity and evolution amongst recent influenza viruses of H1N1 subtype. (1983) (47)
Update: influenza activity--United States, August 30, 2009-January 9, 2010. (2010) (46)
Genetic and antigenic analyses of influenza A (H1N1) viruses, 1986-1991. (1993) (46)
A Global Lab Against Influenza (2001) (43)
Human Heat shock protein 40 (Hsp40/DnaJB1) promotes influenza A virus replication by assisting nuclear import of viral ribonucleoproteins (2016) (43)
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). (2005) (42)
Seasonal and pandemic influenza surveillance considerations for constructing multicomponent systems (2009) (42)
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). (2003) (42)
The Wilhelmine E. Key 1999 Invitational lecture. Predicting the evolution of human influenza A. (2000) (42)
Pause on avian flu transmission research. (2012) (41)
Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets. (2011) (41)
Divergent seasonal patterns of influenza types A and B across latitude gradient in Tropical Asia (2016) (40)
H7N9: preparing for the unexpected in influenza. (2015) (40)
Antigenic and genomic analyses of influenza A(H1N1) viruses from different regions of the world, February 1978 to March 1980 (1981) (40)
Influenza A viral nucleoprotein interacts with cytoskeleton scaffolding protein α‐actinin‐4 for viral replication (2014) (40)
Influenza seasonality: timing and formulation of vaccines. (2014) (39)
Genetic stability of A/Ann Arbor/6/60 cold-mutant (temperature-sensitive) live influenza virus genes: analysis by oligonucleotide mapping of recombinant vaccine strains before and after replication in volunteers. (1984) (38)
Influenza: Global surveillance for epidemic and pandemic variants (1994) (38)
Prevention and control of influenza: Part I, Vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP). (1993) (38)
Development of an Influenza Virologic Risk Assessment Tool (2012) (38)
Robust Sequence Selection Method Used To Develop the FluChip Diagnostic Microarray for Influenza Virus (2006) (37)
Preparing for pandemic influenza: the need for enhanced surveillance. (2002) (37)
Transmission Studies Resume for Avian Flu (2013) (37)
Influenza A(H1N1)pdm09 Virus among Healthy Show Pigs, United States (2012) (37)
Update: influenza activity - United States, August 30-October 31, 2009. (2009) (36)
Diagnostic microarray for influenza B viruses. (2007) (35)
Laboratory properties of cold-adapted influenza B live vaccine strains developed in the US and USSR, and their B/Ann Arbor/1/86 cold-adapted reassortant vaccine candidates. (1990) (35)
Genetic stability of cold-adapted A/Leningrad/134/47/57 (H2N2) influenza virus: sequence analysis of live cold-adapted reassortant vaccine strains before and after replication in children. (1995) (34)
Multiplication of influenza virus in the presence of cordycepin, an inhibitor of cellular RNA synthesis. (1973) (34)
Evaluation of the Subtype Specificity of Monoclonal Antibodies Raised against H1 and H3 Subtypes of Human Influenza A Virus Hemagglutinins (2002) (32)
Pause on Avian Flu Transmission Research (2012) (32)
Genetic analysis of avian influenza A viruses isolated from domestic waterfowl in live-bird markets of Hanoi, Vietnam, preceding fatal H5N1 human infections in 2004 (2009) (31)
Identification of Molecular Markers Associated with Alteration of Receptor-Binding Specificity in a Novel Genotype of Highly Pathogenic Avian Influenza A(H5N1) Viruses Detected in Cambodia in 2013 (2014) (31)
Protection against virulent H5 avian influenza virus infection in chickens by an inactivated vaccine produced with recombinant vaccinia virus. (1988) (31)
Influenza A Virus Neuraminidase Protein Enhances Cell Survival through Interaction with Carcinoembryonic Antigen-related Cell Adhesion Molecule 6 (CEACAM6) Protein* (2012) (30)
Detection and Characterization of Clade 7 High Pathogenicity Avian Influenza H5N1 Viruses in Chickens Seized at Ports of Entry and Live Poultry Markets in Vietnam (2010) (30)
Kinetics of humoral response in children with acute lymphoblastic leukemia immunized with influenza vaccine in 1993 in Poland. (1997) (30)
Influenza: virology, epidemiology, disease, and prevention. (1994) (30)
Genetic approaches to attenuation of influenza A viruses for man. (1980) (29)
Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine. (2008) (29)
Human influenza: One health, one world (2013) (29)
Quantification of immunoreactive viral influenza proteins by immunoaffinity capture and isotope-dilution liquid chromatography-tandem mass spectrometry. (2011) (29)
Pathogenicity and antigenicity of a new influenza a (H5N1) virus isolated from duck meat (2003) (27)
Update: influenza activity - United States, September 28, 2008--January 31, 2009. (2009) (26)
Development of a new candidate H5N1 avian influenza virus for pre‐pandemic vaccine production (2009) (24)
Inactivated and live attenuated influenza vaccines in young children--how do they compare? (2007) (23)
Molecular epidemiology of influenza A(H3N2) virus reinfections. (2002) (23)
Update: Influenza Activity — United States, September 28–December 6, 2014 (2014) (23)
Strengthening the influenza vaccine virus selection and development process: outcome of the 2nd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at the Centre International de Conférences (CICG) Geneva, Switzerland, 7 to 9 December 2011. (2013) (23)
Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: independent segregation of temperature-sensitivity of virus replication from temperature-sensitivity of virion transcriptase activity during recombination of mutant A/Ann Arbor/6/60 with wild-type H3N2 strain (1979) (23)
Development of influenza A(H7N9) candidate vaccine viruses with improved hemagglutinin antigen yield in eggs (2015) (23)
Biological, genetic and biochemical characterization of a cold-adapted recombinant A/Victoria/3/75 virus and its evaluation in volunteers. (1977) (21)
Comparative studies of wild-type and 'cold-mutant' (temperature sensitive) influenza viruses: geneology of the matrix (M) and non-structural (NS) proteins in recombinant cold-adapted H3N2 viruses. (1977) (21)
Preparing for pandemic influenza: the need for enhanced surveillance. (1999) (21)
New options for the prevention of influenza. (1999) (21)
Use of Highly Pathogenic Avian Influenza A(H5N1) Gain-Of-Function Studies for Molecular-Based Surveillance and Pandemic Preparedness (2014) (20)
Meeting the challenge of emerging pathogens: the role of the United States Air Force in global influenza surveillance. (1997) (20)
INFLUENZA SURVEILLANCE IN RUSSIA BASED ON EPIDEMIOLOGICAL AND LABORATORY DATA FOR THE PERIOD FROM 2005 TO 2012. (2013) (20)
Prevention and Control of Influenza with Vaccines: Interim Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2013 (2013) (20)
Presence of a segmented single-stranded RNA genome in influenza C virus. (1976) (19)
Severe influenza among children and young adults with neurologic and neurodevelopmental conditions - Ohio, 2011. (2012) (19)
Influenza surveillance--United States, 1991-92. (1992) (19)
Update: Influenza Activity — United States, September 29, 2013–February 8, 2014 (2014) (19)
Nonimmunoselected intrastrain genetic variation detected in pairs of high-yielding influenza A (H3N2) vaccine and parental viruses. (1994) (19)
Influenza--United States, 1989-90 and 1990-91 seasons. (1992) (19)
Emergence and Transmission of Amantadine‐Resistant Influenza A in a Nursing Home (2004) (19)
Genes coding for polymerase proteins are essential for attenuation of the cold-adapted A/Leningrad/134/17/57 (H2N2) influenza virus (2001) (19)
Identification of Influenza A/PR/8/34 Donor Viruses Imparting High Hemagglutinin Yields to Candidate Vaccine Viruses in Eggs (2015) (18)
A ten-year China-US laboratory collaboration: improving response to influenza threats in China and the world, 2004–2014 (2019) (17)
Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza virus: detection of mutations in all genes of the A/Ann Arbor/6/60 (H2N2) mutant vaccine donor strain. (1986) (17)
DEVELOPMENT OF COLD RECOMBINANTS OF INFLUENZA VIRUS AS LIVE VIRUS VACCINES (1981) (16)
Prevention and control of influenza. (1986) (16)
Influenza A virus haemagglutinin polymorphism: pleiotropic antigenic variants of A/Shanghai/11/87 (H3N2) virus selected as high yield reassortants. (1993) (15)
Influenza vaccination among the elderly in the United States. (2005) (15)
Report on the second WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Geneva, Switzerland, 5-7 May 2014. (2015) (14)
Comparative studies of A/Leningrad/134/57 wild-type and 47-times passaged cold-adapted mutant influenza viruses: oligonucleotide mapping and RNA-RNA hybridization studies. (1985) (14)
Modeling the effects of updating the influenza vaccine on the efficacy of repeated vaccination (2000) (14)
Prevention and Control of Seasonal Influenza with Vaccines Recommendations of the Advisory Committee on Immunization Practices ( ACIP ) , 2009 department of health and human services Centers for Disease Control and Prevention (2009) (14)
Public Health Implications of Avian Influenza Viruses (2009) (14)
Adamantane-Resistant Influenza Infection During the 2004–05 Season (2008) (14)
Safety Evaluation in Chickens of Candidate Human Vaccines Against Potential Pandemic Strains of Influenza (2003) (14)
Update: Influenza activity--United States, 2002-03 season. (2003) (13)
Genetic relatedness between influenza A (H1N1) viruses isolated from humans and pigs. (1994) (13)
Replication of animal viruses in differentiating muscle cells: influenza virus A. (1977) (13)
Evaluation of MChip with Historic Subtype H1N1 Influenza A Viruses, Including the 1918 “Spanish Flu” Strain (2007) (13)
GENETIC AND BIOCHEMICAL ANALYSIS OF THE A/ANN ARBOR/6/60 COLD-ADAPTED MUTANT (1981) (12)
Generation and Characterization of an H9N2 Cold-Adapted Reassortant as a Vaccine Candidate (2003) (12)
Characterization of Reverse Genetics-Derived Cold-Adapted Master Donor Virus A/Leningrad/134/17/57 (H2N2) and Reassortants with H5N1 Surface Genes in a Mouse Model (2014) (12)
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). (2000) (12)
Effect of D 222 G Mutation in the Hemagglutinin Protein on Receptor Binding , Pathogenesis and Transmissibility of the 2009 Pandemic H 1 N 1 Influenza Virus (2011) (12)
Capacity Building in Response to Pandemic Influenza Threats: Lao PDR Case Study (2012) (12)
31 – Inactivated Influenza Vaccines (2018) (11)
Forecasting the epidemic potential of influenza virus variants based on their molecular properties. (1985) (11)
Multiple lineages co-circulation and genetic reassortment of the neuraminidase and hemagglutinin genes within influenza viruses of the same type/subtype (2001) (10)
The first confirmed human case of avian influenza A (H5N1) in Mainland China. (2006) (10)
ErratumErratum to “In vitro evolution of H5N1 avian influenza virus toward human-type receptor specificity” [Virology 422 (2011) 105–113] (2012) (10)
Progress in Vaccine-Preventable and Respiratory Infectious Diseases—First 10 Years of the CDC National Center for Immunization and Respiratory Diseases, 2006–2015 (2018) (9)
Public health implications of animal influenza viruses (2016) (8)
Influenza activity --- United States and worldwide, June 13-September 25, 2010. (2010) (8)
Recommendations of the 7th European Meeting of Influenza and Its Prevention (1994) (8)
Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP); Vaccines; Part I (1994) (8)
Decreased antibody response among nursing home residents who received recalled influenza vaccine and results of revaccination, 1996-97. (2000) (8)
Prevention and control of influenza; Part II, Antiviral agents : recommendations of the Advisory Committee on Immunization Practices (ACIP) (1994) (7)
Seven integrated influenza surveillance systems in Taiwan (2001) (7)
Update: influenza activity--United States, 2004-05 season. (2005) (7)
New England Medical Journal (2007) (7)
Oligonucleotide mapping of viral ribonucleic acid as an aid in identifying laboratory contaminants of influenza virus. (1986) (6)
Human trials with wild-type H1N1 and recombinant H3N2-H1N1 influenza A viruses of 1977-1978 (1980) (6)
Predicting influenza evolution: the impact of terminal and egg-adapted mutations (2001) (6)
Reassortment between avian apathogenic and human attenuated cold-adapted viruses as an approach for preparing influenza pandemic vaccines (2004) (6)
Pathogenesis of and Immunity to a New Influenza A (H5N1) Virus Isolated from Duck Meat (2003) (6)
Panel summary of international pandemic influenza plans. (1997) (6)
NATURAL AND UNNATURAL VARIATION IN INFLUENZA A(H1N1) VIRUSES SINCE 1977 (1981) (6)
Influenza virus NS1- C/EBPβ gene regulatory complex inhibits RIG-I transcription. (2020) (6)
Hybridization studies of the relationship between influenza virus RNA and cellular DNA. (1976) (5)
Nucleotide sequences of the neuraminidase genes of influenza A/Leningrad/134/57 (H2N2) virus and two of its live, attenuated, cold-adapted variants (2005) (5)
Complex Simplicity and Hirschsprung's Disease. (2019) (5)
Alternative models for estimating influenza-attributable P&I deaths in the US (2001) (5)
Influenza surveillance in poultry market and its inter-species transmission in Taiwan (2001) (4)
Update: influenza activity --- United States, October 3-December 11, 2010. (2010) (4)
Influenza--United States, 1988-89. (1993) (4)
Replication of animal viruses in differentiating muscle cells: vaccinia and herpes simplex virus type 1. (1978) (4)
Partnerships for detecting emerging infectious diseases: Nepal and global influenza surveillance. (1998) (4)
Evolutionary analysis of human H2N2 and early H3N2 influenza viruses: evidence for genetic divergence and multiple reassortment among H2N2 and/or H3N2 viruses (2004) (4)
Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices ( ACIP ) Prepared by (2005) (4)
Update: Influenza Activity — United States, September 29–December 7, 2013 (2013) (4)
Effect of temperature on the order of electrophoretic migration of influenza virus neuraminidase and nucleoprotein genes in acrylamide gels lacking denaturing agents. (1978) (4)
Antigenic and Genetic Variation of Influenza A(H1N1) Viruses (1990) (4)
Update: Influenza Activity — United States and Worldwide, May 18–September 20, 2014 (2014) (4)
[Formation of humoral and secretory immunity in elderly persons with different schemes of immunization with flu vaccines]. (1998) (3)
Update: Influenza Activity — United States, September 30, 2012–February 9, 2013 (2013) (3)
Antigenic characteristics of recent avian influenza A H5N1 viruses isolated from humans (2004) (3)
Development of candidate H7N3 live attenuated influenza vaccine (2008) (3)
Influenza surveillance with rapid diagnostic tests. (2002) (3)
Age-specific estimates of US influenza-associated deaths and hospitalizations (2004) (3)
Influenza pandemic plan: integrated wild bird/domestic avian/swine/human flu surveillance systems in Taiwan (2004) (3)
Influenza pandemic planning: review of a collaborative state and national process (2001) (3)
Live attenuated reassortant influenza vaccine prepared using A/Leningrad/134/17/57 (H2N2) donor strain is genetically stable after replication in children 3-6 years of age (2001) (3)
Prospecting the influenza hemagglutinin to develop universal vaccines. (2011) (3)
Global Influenza Surveillance and Response System: 70 years of responding to the expected and preparing for the unexpected (2022) (2)
Update: Influenza Activity — United States and Worldwide, May 19–September 28, 2013 (2013) (2)
Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. Commentary (2006) (2)
So many questions, so little time. (2013) (2)
Options for the control of influenza IV : proceedings of the World Congress on Options for the Control of Influenza IV held in Crete, Greece, 23rd-28th September 2000 (2001) (2)
Pandemic Virus Characterization of the Reconstructed 1918 Spanish Influenza (2012) (2)
A protein network of one's own proteins (2005) (2)
[Vaccination against influenza in children with acute lymphoblastic leukemia]. (1996) (2)
[In vitro proliferative activity of lymphocytes from elderly persons after separate and combined immunization with live and inactivated flu vaccines]. (2000) (2)
[Production of interleukin-2 in vitro and in vivo in elderly people, vaccinated with live and inactivated flu vaccines separately and combined]. (2000) (2)
XIth International Symposium on Respiratory Viral Infections (2011) (1)
Human influenza surveillance in areas with animal flu epidemics and China visitors in Taiwan (2004) (1)
Shift Shown in Influenza A Adamantane Resistance—Reply (2006) (1)
Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices ( ACIP ) , 2008 department of health and human services Centers for Disease Control and Prevention (2008) (1)
[Influenza vaccination of children with hemophilia]. (1995) (1)
Molecular epidemiology of influenza virus isolated in Brazil from 1996 to 2000 (2004) (1)
Infectious Disease and Host–Pathogen Evolution: Influenza Evolution (2004) (1)
ANTIGENIC DRIFT OF THE H1 SUBTYPE HAEMAGGLUTININ FROM 1977 TO 1980 (1984) (1)
Genome evolution of human epidemic influenza viruses (1988) (1)
Receptor Specificity of Influenza A H3N2 Viruses Isolated in Mammalian Cells and Embryonated Chicken Eggs (2010) (1)
GENETIC STABILITY OF A/ANN ARBOR/6/60 COLD-MUTANT (TEMPERATURE-SENSITIVE) LIVE INFLUENZA VACCINE STRAINS (1984) (1)
J. Virol. Methods (1995) (1)
The detection of hepatitis A and astroviruses in river and dam water (2000) (0)
Prevention and Control of Seasonal Influenza with Vaccines Recommendations of the Advisory Committee on Immunization Practices ( ACIP ) , 2009 Prepared by (2009) (0)
Morbidity and Mortality Weekly Report (2003) (0)
New approaches to large-scale data integration: Across-omics and across variant types (2014) (0)
Update: Influenza Activity--United States, 2004-05 Season: (401052005-006) (2013) (0)
Prevention and control of influenza. (1999) (0)
Crystal Structure of the Hemagglutinin from a H1N1pdm A/WASHINGTON/5/2011 virus (2014) (0)
[Immune response of elderly persons depending on the number of annual seasonal immunizations of live and inactivated influenza vaccines]. (1998) (0)
, David A ( H 1 N 1 ) pdm 09 Virus Hemagglutinins Structural Stability of Influenza (2014) (0)
Production of interleukin-2 in vitro and in vivo in elderly subjects vaccinated with live and inactivated influenza vaccines and their combination. (2000) (0)
Shift shown in influenza a Adamantane resistance. Authors' reply (2006) (0)
Antibody response to a sub-potent influenza vaccine among nursing home residents and results of revaccination, New York, 1996-97 (1997) (0)
Comparisons with other data sets Health outcomes : Hospitalizations Non-high risk : High risk : Comparisons with other data sets : (2019) (0)
Receptor Speciﬁcity of Inﬂuenza A H3N2 Viruses Isolated in Mammalian Cells and Embryonated Chicken Eggs (cid:1) (2010) (0)
Genetic and antigenic analysis of the neuraminidase of influenza B viruses: association of neuraminidase in global spread and recycling of influenza B/Victoria/2/87-like viruses (2004) (0)
INFLUENZA A VIRUS NEURAMINIDASE PROTEIN ENHANCES CELL SURVIVAL THROUGH INTERACTION WITH CEACAM6 (2012) (0)
Crystal structure of influenza hemagglutinin (H5) in complex with a broadly neutralizing antibody F10 (2009) (0)
Influenza present: the impact of the 1999–2000 epidemic on morbidity and mortality in the USA (2001) (0)
Detection and Characterization of Clade 7 High Pathogenicity Avian Influenza H5N1 Viruses in Chickens Seized at Ports of Entry and Live Poultry Markets in Vietnam (2010) (0)
Influenza pandemic vaccines: the imminent challenges from a technical and regulatory perspective (2004) (0)
Antigenic and Genetic Diversity of Highly Pathogenic Avian Influenza A (H5N1) Viruses Isolated in Egypt (2010) (0)
An Action Plan for improving international influenza surveillance (2004) (0)
Vaccines against avian influenza A H9N2 viruses (2001) (0)
Persistent influenza infection of a child with severe combined immunodeficiency syndrome (1985) (0)
Imported Tickborne Relapsing Fever, France (2005) (0)
The CDC's recommendations for preventing and controlling influenza (2002) (0)
Development and evaluation of candidate influenza a vaccines for pandemic preparedness (2004) (0)
Genetic and Antigenic Characterization of Avian Influenza A (H5N1) Viruses Isolated from Humans in Mainland China (2008) (0)
Generation of candidate H5N1 and H9N2 influenza vaccines for pandemic preparedness (2001) (0)
rapidinfluenza viruses in clinical specimens by Type-and subtype-specific detection of (1994) (0)
Memoranda IMemorandums Cell culture asasubstrate fortheproduction of influenza vaccines: MemorandumfromaWHO meeting* (1995) (0)
[Analysis of the antigenic structure of influenza A/USSR/90/77 virus hemagglutinin]. (1984) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Nancy J. Cox?

Nancy J. Cox is affiliated with the following schools:

Nancy J. Cox's Academic­Influence.com Rankings

Nancy J. Cox's Degrees

Why Is Nancy J. Cox Influential?

Nancy J. Cox's Published Works

Published Works

What Schools Are Affiliated With Nancy J. Cox?

Nancy J. Cox's AcademicInfluence.com Rankings